Advertisement
U.S. Markets open in 9 hrs 29 mins

Biotest Aktiengesellschaft (BIO3.DE)

XETRA - XETRA Delayed Price. Currency in EUR
27.700.00 (0.00%)
At close: 05:36PM CEST
Currency in EUR

Valuation Measures4

Market Cap (intraday) 1.38B
Enterprise Value 1.87B
Trailing P/E 6.67
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)1.11
Price/Book (mrq)2.05
Enterprise Value/Revenue 2.39
Enterprise Value/EBITDA 9.29

Trading Information

Stock Price History

Beta (5Y Monthly) 0.24
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 331.80
52 Week Low 322.80
50-Day Moving Average 326.80
200-Day Moving Average 327.62

Share Statistics

Avg Vol (3 month) 3656
Avg Vol (10 day) 3554
Shares Outstanding 519.79M
Implied Shares Outstanding 6N/A
Float 820.79M
% Held by Insiders 10.00%
% Held by Institutions 10.97%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 40.04
Forward Annual Dividend Yield 40.14%
Trailing Annual Dividend Rate 30.04
Trailing Annual Dividend Yield 30.14%
5 Year Average Dividend Yield 40.15
Payout Ratio 40.96%
Dividend Date 3N/A
Ex-Dividend Date 4May 08, 2024
Last Split Factor 23:1
Last Split Date 3Jul 15, 2015

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Jun 30, 2024

Profitability

Profit Margin 21.04%
Operating Margin (ttm)16.33%

Management Effectiveness

Return on Assets (ttm)8.47%
Return on Equity (ttm)36.16%

Income Statement

Revenue (ttm)781.3M
Revenue Per Share (ttm)25.05
Quarterly Revenue Growth (yoy)-0.80%
Gross Profit (ttm)N/A
EBITDA 206.6M
Net Income Avi to Common (ttm)164.4M
Diluted EPS (ttm)4.15
Quarterly Earnings Growth (yoy)-56.30%

Balance Sheet

Total Cash (mrq)66.3M
Total Cash Per Share (mrq)1.64
Total Debt (mrq)624.3M
Total Debt/Equity (mrq)116.50
Current Ratio (mrq)2.45
Book Value Per Share (mrq)13.26

Cash Flow Statement

Operating Cash Flow (ttm)118.9M
Levered Free Cash Flow (ttm)1.45M